Undiagnosed COPD and Asthma Population Study (UCAP) - Trial NCT03148210
Access comprehensive clinical trial information for NCT03148210 through Pure Global AI's free database. This phase not specified trial is sponsored by Ottawa Hospital Research Institute and is currently Active, not recruiting. The study focuses on Asthma,COPD. Target enrollment is 508 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ottawa Hospital Research Institute
Timeline & Enrollment
N/A
Jun 05, 2017
Jan 13, 2024
Primary Outcome
Annual rate of patient initiated healthcare utilization events for respiratory illness
Summary
Previous population health studies suggest that up to 10% of Canadian adults have undiagnosed
 asthma or COPD- these people are currently undiagnosed and untreated, even though they may
 have significant respiratory symptoms. Our study will use targeted casefinding to find people
 with undiagnosed asthma and COPD in Canadian communities. The investigators will assess their
 symptoms and their health care use and number of sick days to determine the burden of
 undiagnosed respiratory disease in these people. The investigators will then determine
 whether early treatment of previously undiagnosed airflow obstruction will improve patients'
 health outcomes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03148210
Non-Device Trial